Target intelligence / Profile preview

Human immunodeficiency virus type 1 envelope glycoprotein gp41 membrane proximal external region (HIV-1 gp41 MPER)

Target
HIV-1 gp41 MPER
Molecular classification
Viral envelope protein, Fusion protein, Other
01

Overview

The Membrane Proximal External Region (MPER) of the HIV-1 envelope glycoprotein gp41 is a highly conserved, tryptophan-rich segment located adjacent to the viral transmembrane domain (PMID: 18617515). It is essential for the viral-cell membrane fusion process, acting as a hinge or anchor that facilitates the transition of gp41 into its post-fusion conformation (PMID: 22633865). The MPER is a major target for broadly neutralizing antibodies (bNAbs), most notably 2F5, which recognizes the conserved ELDKWA motif (PMID: 11069997). Because this region is critical for entry and highly conserved across diverse HIV-1 clades, it is a high-priority target for both passive immunotherapy and vaccine development (PMID: 24403135). However, the MPER is often shielded by the viral membrane or other parts of the envelope spike, making it difficult for antibodies to access (PMID: 23152514). Therapeutic challenges include the potential for MPER-targeting antibodies to exhibit polyreactivity or autoreactivity with host lipids, such as cardiolipin (PMID: 15860610).

Other names
MPERMembrane proximal external regiongp41 MPER2F5 epitopeHIV-1 gp41 MPER 2F5 epitope
02

Mechanism of action

Neutralization of HIV-1 by binding to the MPER region, which sterically hinders the conformational transition of gp41 into the six-helix bundle required for fusion between the viral envelope and the host cell membrane (PMID: 18617515).

03

Biological functions

Immune responseOther
04

Disease associations

Infection
05

Safety considerations

Antibody polyreactivityAutoreactivity with host lipids (e.g., cardiolipin)Low immunogenicity in vaccine contextsStructural masking by the viral membrane
06

Interacting drugs

2F5 (monoclonal antibody)

4 more in the full profile.

07

Biomarkers

Anti-MPER antibody titersHIV-1 viral loadCD4+ T-cell count

Beyond the preview

Go deeper on Human immunodeficiency virus type 1 envelope glycoprotein gp41 membrane proximal external region (HIV-1 gp41 MPER).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human immunodeficiency virus type 1 envelope glycoprotein gp41 membrane proximal external region (HIV-1 gp41 MPER).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call